PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 21, 2026Frontiers in Immunology0 citationsOpen Access

NOD1 modulates chronic obstructive pulmonary disease progression via FOXA1/NLRP3-mediated regulation of pyroptosis

View Full Paper
WXWenzhi XieHXHui XuHSHongmei Shu

Key Points

  • The aim is to explore how NOD1 affects cell death and inflammation in COPD.
  • Established bronchial epithelial cell models and animal models of COPD.
  • Conducted transcriptomic and functional analyses to examine signaling pathways.
  • Utilized NOD1 knockout and NLRP3 overexpression techniques to assess effects on pyroptosis.
  • NOD1 promotes pyroptosis in COPD through the FOXA1-NLRP3 signaling axis.
  • Knockout of NOD1 increased cell survival, showing a protective effect in COPD models.
  • NLRP3 overexpression reversed the benefits of NOD1 knockout, highlighting its role in inflammation.

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by persistent airway inflammation and progressive airflow limitation. In this study, we established cellular models of COPD using bronchial epithelial cells and also constructed animal models to verify the protective effect of NOD1 knockout on lung tissue in COPD model mice, aiming to elucidate the molecular events linking increased NOD1 expression to inflammatory cell death. Transcriptomic and functional analyses revealed that NOD1 promotes pyroptosis in COPD via the FOXA1-NLRP3 signaling axis, with the PI3K-Akt pathway mediating these effects. Mechanistically, NOD1 suppresses FOXA1, leading to upregulation of NLRP3 and enhanced release of pro-inflammatory cytokines IL-18 and IL-1β. Knockdown of NOD1 alleviated pyroptosis and improved cell survival, effects reversed by NLRP3 overexpression. In conclusion, our findings identify the NOD1–FOXA1–NLRP3 axis as a key driver of inflammatory cell death in COPD, advancing our understanding of disease pathogenesis and highlighting potential molecular targets for therapeutic intervention.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Xie et al. (2026) studied this question.

synapsesocial.com/papers/69e7132bcb99343efc98ceb4https://doi.org/10.3389/fimmu.2026.1800191
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1NOD1 deficiency ameliorates the progression of diabetic retinopathy by modulating bone marrow–retina crosstalk2024 · 10 citations
  2. 2Peroxiredoxin 1 mediates bleomycin-induced acute lung injury in mice via macrophage NOD1/NF-κB axis2026 · 1 citations
  3. 3COPD is associated with increased cardiovascular disease risk independent of phenotype2024 · 31 citations
  4. 4Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD2012 · 58 citations
  5. 5Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo2006 · 211 citations